Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC Mesenchymal Stem Cells for Induction of Remission in Ulcerative Colitis
2010-023798-20Phase 2Active
- Sponsor
- FIBHULP
- Start
- May 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of adipose derived mesenchymal stromal cells in autoimmune colitis, sponsored by FIBHULP. Primary endpoints: Safety of ASC and Induction of remission. Started May 2012; status: active.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2010-023798-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023798-20.